← Open Payments lookup

ELIZABETH SCOTT: Open Payments

NPI 1982106753 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$605 in 27 payments from 13 companies in 2025. Trend: 2023 $267 · 2024 $323 · 2025 $605

Food & beverage: $605
CompanyPaymentsAmount
CSL Behring4$131
Merz Pharmaceuticals, LLC4$118
Takeda Pharmaceuticals U.S.A., Inc.3$70
Novartis Pharmaceuticals Corporation2$57
Bayer Healthcare Pharmaceuticals Inc.2$50
Boehringer Ingelheim Pharmaceuticals, Inc.3$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
Merck Sharp & Dohme LLC2$34
TerSera Therapeutics LLC1$20
Alnylam Pharmaceuticals Inc.1$17

Products named: Hizentra, Xeomin, Kerendia, FRUZAQLA, JARDIANCE, RELISTOR, LUTATHERA, CAPVAXIVE.

Industry payments across AL — which companies pay providers there.